| Part Of Safety of Arthritis Drugs, Day 3,

Safety of Arthritis Drugs, Day 3, Part 3

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs… read more

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave a presentation on the FDA’s regulatory options used for problem drugs. Options included labeling details, limitations on drug amounts, restriction of prescriptions, and market withdrawal. The committee members questioned her and continued assessing the safety records of arthritis drugs.

The function of the advisory committees, chaired by Dr. Alastair Wood, was to provide advice and recommendations to the FDA on regulatory issues. close

Report Video Issue

People in this video

  • Steven Abramson Chair New York University Medical School->Rheumatology
  • Joan Bathon Professor Johns Hopkins University School of Medicine
  • John Cush Chief Presbyterian Hospital (Dallas)->Rheumatology and Immunology
  • Ruth Day Senior Fellow Duke University->Aging Center
  • John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
  • Thomas Fleming Historian
  • Lawrence Friedman Official National Institutes of Health
  • Curt Furberg Director Wake Forest University->Department of Public Health Services
  • Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
  • Peter Gross M.D. Chairman Hackensack University Medical Center->Internal Medicine
  • Charles Hennekens Professor University of Miami->School of Medicine
  • Gary Hoffman Research Director Cleveland Clinic Foundation->Vasculitis Center
  • Eric Holmboe Vice President American Board of Internal Medicine->Evaluation Research
  • Norman Ilowite Chief Schneider Children's Hospital
  • John Jenkins Director U.S. Food and Drug Administration->Office of New Drugs
  • Leona Malone
  • Susan Manzi Professor University of Pittsburgh->School of Medicine
  • Louis Morris President Louis A. Morris and Associates
  • Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
  • Richard Platt Director Harvard Medical School->Ambulatory Care and Prevention
  • Steven Shafer M.D. Professor Stanford University->Medical School
  • Robyn Shapiro Professor Medical College of Wisconsin->Bioethics
  • Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
  • Anne Trontell Deputy Director U.S. Food and Drug Administration->Drug Safety
  • Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 3,

More Videos
More information about

Safety of Arthritis Drugs, Day 3, Part 3

236 Views
Program ID:
185600-3
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 25, 2005 | 11:55am EST | C-SPAN 2

Airing Details

  • Feb 25, 2005 | 11:55am EST | C-SPAN 2
Purchase a Download

Safety of Arthritis Drugs, Day 3, Part 3

  • MP3 audio - Standard
    Price:
    $0.99
    Request Download